Streptozocin
CAS 18883-66-4 2 FDA-DMF suppliersSmall Molecule
Overview
Streptozocin is a naturally occurring nitrosourea with antineoplastic activity. It is used primarily for the treatment of pancreatic islet cell carcinoma. Its mechanism of action involves the alkylation of DNA, leading to inhibition of DNA synthesis and function.
Therapeutic areas
Oncology
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.